Table 2. Clinical and immunologic data from patients with diffuse cutaneous leishmaniasis (DCL) and localized cutaneous leishmaniasis (LCL).

						Lesions
Patients (N°)	Pathology	Sex	Age in the begining of the disease	Duration of disease (months)	LST	Nodules	Ulcers	Number
1	DCL	M	23	60	Neg.	++++	0	>500
2	DCL	M	06	144	Neg.	+++	6	51
3	DCL	M	20	180	Neg.	+++	0	168
4	DCL	M	04	276	Neg.	++	0	20
5	DCL	F	07	180	Neg.	+++	0	140
6	DCL	M	22	120	Neg.	+++	+	68
7	DCL	M	41	36	Neg.	++	0	22
8	LCL	M	64	04	+32mm	−	+	8
9	LCL	M	54	01	+25mm	−	+	2
10	LCL	M	70	02	+10mm	−	+	1
11	LCL	F	08	03	+12mm	−	+	5
12	LCL	M	27	06	+25mm	−	+	1

LST, Leishmanin Skin Test. –, no nodules; +, few; ++, moderate; +++, intense; ++++, very intense.